Limitations of homoeopathic research - challenges in applying AI like chat GPT

Abstract

The integration of Artificial Intelligence (AI), particularly models like ChatGPT, into homoeopathy represents an innovative yet complex advancement in healthcare research. This exploration highlights AI’s potential in enhancing symptom analysis, drug proving, and pathogenetic trials (HPTs), while also addressing critical limitations. The major concerns include the lack of empirical validation of homoeopathy, unreliable and anecdotal data sources, and the inability of AI to capture the holistic and individualized nature of treatment. Ethical challenges involving data privacy, patient autonomy, and regulatory compliance further complicate AI’s adoption in this domain. Moreover, the interplay between human expertise and AI-assisted decision-making must be carefully balanced to preserve clinical judgment. While AI can support data analysis and research design, it should complement rather than replace homoeopathic practitioners. Future integration demands scientific rigor, robust datasets, ethical oversight, and clear regulatory frameworks to ensure responsible and effective implementation.